This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
V. J. Hall, S. Foulkes, A. Saei, N. Andrews, B. Oguti, A. Charlett, E. Wellington, J. Stowe, N. Gillson, A. Atti, J. Islam, I. Karagiannis, K. Munro, J. Khawam, M. A. Chand, C. S. Brown, M. Ramsay, J. Lopez-Bernal, S. Hopkins, and SIREN study group, COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study, Lancet (London) 397(10286) (2021) 1725–1735; https://doi.org/10.1016/S0140-6736(21)00790-XSearch in Google Scholar
J. S. Tregoning, K. E. Flight, S. L. Higham, Z. Wang and B. F. Pierce, Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape, Nat. Rev. Immunol.21(10) (2021) 626–636; https://doi.org/10.1038/s41577-021-00592-1Search in Google Scholar
A. Kazak, S. Hintistan and Ö. Betül, Dünyada ve Türkiye’de COVID-19 aşı geliştirme çalışmaları (COVID-19 vaccine development studies in the world and in Turkey), Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi (J. Celal Bayar Uni. Health Sci. Inst.) 7(4) (2020) 571–575; https://doi.org/10.348087/cbusbed.749009Search in Google Scholar
M. D. Tanrıöver, H. L. Doğanay, M. Akova, H. R. Güner, A. Azap, S. Akhan, Ş. Köse, F. Ş. Erdinç, E. H. Akalın, Ö. F. Tabak, H. Pullukçu, Ö. Batum, S. Ş. Yavuz, Ö. Turhan, M. T. Yıldırmak, İ. Köksal, Y. Taşova, V. Korten, G. Yılmaz, M. K. Çelen, S. Altin, İ. Çelik, Y. Bayındır, İ. Karaoğlan, A. Yılmaz, A. Özkul, H. Gür, S. Unal, and the CoronaVac study group, Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey, Lancet (London) 398(10296) (2021) 213–222; https://doi.org/10.1016/S0140-6736(21)01429-XSearch in Google Scholar
T. Fiolet, Y. Kherabi, C. J. MacDonald, J. Ghosn and N. Peiffer-Smadja, Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review, Clin. Microb. Infect.28(2) (2022) 202–221; https://doi.org/10.1016/j.cmi.2021.10.005Search in Google Scholar
M. G. Thompson, J. L. Burgess, A. L. Naleway, H. L. Tyner, S. K. Yoon, J. Meece, L. E. W. Olsho, A. J. Caban-Martinez, A. Fowlkes, K. Lutrick, J. L. Kuntz, K. Dunnigan, M. J. Odean, K. T. Hegmann, E. Stefanski, L. J. Edwards, N. Schaefer-Solle, L. Grant, K. Ellingson, H. C. Groom, T. Zunie, M. S. Thiese, L. Ivacic, M. G. Wesley, J. M. Lamberte, X. Sun, M. E. Smith, A. L. Phillips, K. D. Groover, Y. M. Yoo, J. Gerald, R. T. Brown, M. K. Herring, G. Joseph, S. Beitel, T. C. Morrill, J. Mak, P. Rivers, K. M. Harris, D. R. Hunt, M. L. Arvay, P. Kutty, A. M. Fry, M. Gaglani, Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers – Eight U.S. locations, December 2020-March 2021, Morb. Mortal. Weekly Rep. 70(13) (2021) 495–500; https://doi.org/10.15585/mmwr.mm7013e3Search in Google Scholar
V. Hall, S. Foulkes, F. Insalata, P. Kirwan, A. Saei, A. Atti, E. Wellington, J. Khawam, K. Munro, M. Cole, C. Tranquillini, A. Taylor-Kerr, N. Hettiarachchi, D. Calbraith, N. Sajedi, I. Milligan, Y. Themistocleous, D. Corrigan, L. Cromey, L. Price, S. Stewart, E. de Lacy, C. Norman, E. Linley, A. D. Otter, A. Semper, J. Hewson, S. D’Arcangelo, M. Chand, C. S. Brown, T. Brooks, J. Islam, A. Charlett and S. Hopkins (for the SIREN Study Group), Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection, N. Engl. J. Med. 386 (2022) 1207–1220; https://doi.org/10.1056/NEJMoa2118691Search in Google Scholar
N. Andrews, J. Stowe, F. Kirsebom, S. Toffa, T. Rickeard, E. Gallagher, C. Gower, M. Kall, N. Groves, A.-M. O’Connell, D. Simons, P. B. Blomquist, A. Zaidi, S. Nash, N. I. B. A. Aziz, S. Thelwall, G. Dabrera, R. Myers, G. Amirthalingam, S. Gharbia, J. C. Barrett, R. Elson, S. N. Ladhani, N. Ferguson, M. Zambon, C. N. J. Campbell, K. Brown, S. Hopkins, M. Chand, M. Ramsay and J. Lopez Bernal, Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant, New Engl. J. Med.386(16) (2022) 1532–1546; https://doi.org/10.1056/NEJMoa2119451Search in Google Scholar
European Centre for Disease Prevention and Control, Implications of the Further Emergence and Spread of the SARS CoV-2 B.1.1.529 Variant of Concern (Omicron) for the EU/EEA – first update, December 2, 2021; https://www.ecdc.europa.eu/sites/default/files/documents/threat-assessment-covid-19-emergence-sars-cov-2-variant-omicron-december-2021.pdf; last access data March 3, 2023.Search in Google Scholar
R. R. Goel, M. M. Painter, S. A. Apostolidis, D. Mathew, W. Meng, A. M. Rosenfeld, K. A. Lund-green, A. Reynaldi, D. S. Khoury, A. Pattekar, S. Gouma, L. Kuri-Cervantes, P. Hicks, S. Dysinger, A. Hicks, H. Sharma, S. Herring, S. Korte, A. E. Baxter, D. A. Oldridge, J. R. Giles, M. E. Weirick, C. M. McAllister, M. Awofolaju, N. Tanenbaum, E. M. Drapeau, J. Dougherty, S. Long, K. D’Andrea, J. T. Hamilton, M. McLaughlin, J. C. Williams, S. Adamski, O. Kuthuru, U. Penn COVID Processing Unit; I. Frank, M. R. Betts, L. A. Vella, A. Grifoni, D. Weiskopf, A. Sette, S. E. Hensley, M. P. Davenport, P. Bates, E. T. Luning Prak, A. R. Greenplate and E. J. Wherry, mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern, Science (New York) 374(6572) (2021) Article ID 1214 (17 pages); https://doi.org/10.1126/science.abm0829Search in Google Scholar
Y. M. Bar-On, Y. Goldberg, M. Mandel, O. Bodenheimer, L. Freedman, N. Kalkstein, B. Mizrahi, S. Alroy-Preis, N. Ash, R. Milo and A. Huppert, Protection of BNT162b2 vaccine booster against Covid-19 in Israel, New Engl. J. Med. 385(15) (2021) 1393–1400; https://doi.org/10.1056/NEJMoa2114255Search in Google Scholar
D. S. Khoury, D. Cromer, A. Reynaldi, T. E. Schlub, A. K. Wheatley, J. A. Juno, K. Subbarao, S. J. Kent, J. A. Triccas and M. P. Davenport, Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection, Nat. Med. 27(7) (2021) 1205–1211; https://doi.org/10.1038/s41591-021-01377-8Search in Google Scholar
World Health Organization, WHO COVID-19 Case Definition – Updated in Public health surveil-lance for COVID-19, WHO, 22 July 2022; https://www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2020; last access date March 3, 2023.Search in Google Scholar
Republic of Turkey – Ministry of Health, Covid-19 Vaccine Information Platform, Covid-19 Aşısı Ulusal Uygulama Stratejisi (Covid-19 Vaccine National Implementation Strategy); https://covid19asi.saglik.gov.tr/TR-77706/covid-19-asisi-ulusal-uygulama-stratejisi.htmlSearch in Google Scholar
C. K. P. Mok, C. A. Cohen, S. M. S. Cheng, C. Chen, K. O. Kwok, K. Yiu, T. O. Chan, M. Bull, K. C. Ling, Z. Dai, S. S. Ng, G. C. Lui, C. Wu, G. K. Amarasinghe, D. W. Leung, S. Y. S. Wong, S. A. Valkenburg, M. Peiris and D. S. Hui, Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 vaccines in Hong Kong, Respirology (Carlton, Vic.) 27(4) (2022) 301–310; https://doi.org/10.1111/resp.14191Search in Google Scholar
F. Rammauro, F. Carrión, N. Olivero-Deibe, M. Fló, A. Ferreira, O. Pritsch and S. Bianchi, Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2, Vaccine40(35) (2022) 5189–5196; https://doi.org/10.1016/j.vaccine.2022.07.023Search in Google Scholar
W. W. Lim, L. Mak, G. M. Leung, B. J. Cowling and M. Peiris, Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19, Lancet Microbe2(9) (2021) e423; https://doi.org/10.1016/S2666-5247(21)00177-4Search in Google Scholar
Y. E. Kim, K. Huh, Y. J. Park, K. R. Peck and J. Jung, Association between vaccination and acute myocardial infarction and ischemic stroke after COVID-19 infection, JAMA328(9) (2022) 887–889; https://doi.org/10.1001/jama.2022.12992Search in Google Scholar
J. Xie, Z. Tong, X. Guan, B. Du, H. Qiu and A. S. Slutsky, Critical care crisis and some recommendations during the COVID-19 epidemic in China, Int. Care Med. 46(5) (2020) 837–840; https://doi.org/10.1007/s00134-020-05979-7Search in Google Scholar
B. Sandalc, O. A. Uyaroğlu and G. S. Güven, COVID-19’da kronik hastalıkların rolü, önemi ve öneriler (The role and importance of chronic diseases in COVID-19 and related recommendations), Flora25(2) (2020) 132–138; https://doi.org/10.5578/flora.69700Search in Google Scholar
Y. Zou, D. Huang, Q. Jiang, Y. Guo and C. Chen, The vaccine efficacy against the SARS-CoV-2 Omicron: A systemic review and meta-analysis, Front. Public Health10 (2022) Article ID 940956 (9 pages); https://doi.org/10.3389/fpubh.2022.940956Search in Google Scholar
L. Wang, M. H. Kainulainen, N. Jiang, H. Di, G. Bonenfant, L. Mills, M. Currier, P. Shrivastava-Ranjan, B. M. Calderon, M. Sheth, B. R. Mann, J. Hossain, X. Lin, S. Lester, E. A. Pusch, J. Jones, D. Cui, P. Chatterjee, M. H. Jenks, E. K. Morantz, G. P. Larson, M. Hatta, J. L. Harcourt, A. Tamin, Y. Li, Y. Tao, K. Zhao, K. Lacek, A. Burroughs, W. Wang, M. Wilson, T. Wong, S. H. Park, S. Tong, J. R. Barnes, M. W. Tenforde, W. H. Self, N. I. Shapiro, M. C. Exline, D. C. Files, K. W. Gibbs, D. N. Hager, M. Patel, A. L. Halpin, L. K. McMullan, J. S. Lee, H. Xia, X. Xie, P.-Y. Shi, C. T. Davis, C. F. Spiropoulou, N. J. Thornburg, M. S. Oberste, V. G. Dugan, SSEV Bioinformatics Working Group, D. E. Wentworth and B. Zhou, Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines, Nature Commun.13(1) (2022) Article ID 4350 (10 pages); https://doi.org/10.1038/s41467-022-31929-6Search in Google Scholar
M. J. Cohen, Y. Oster, A. E. Moses, A. Spitzer, S. Benenson and Israeli-Hospitals 4th Vaccine Working Group, Association of receiving a fourth dose of the BNT162b vaccine with SARS-CoV-2 infection among health care workers in Israel, JAMA Network Open5(8) (2022) e2224657 (7 pages); https://doi.org/10.1001/jamanetworkopen.2022.24657Search in Google Scholar
V. K. C. Yan, E. Y. F. Wan, X. Ye, A. H. Y. Mok, F. T. T. Lai, C. S. L. Chui, X. Li, C. K. H. Wong, P. H. Li, T. Ma, S. Qin, V. K. C. Wong, T. C. Tsang, S. H. Tsui, W. C. M. Chui, B. J. Cowling, G. M. Leung, C. S. Lau, I. C. K. Wong and E. W. Y. Chan, Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study, Emerg. Microbes Infect. 11(1) (2022) 2304–2314; https://doi.org/10.1080/22221751.2022.2 114854Search in Google Scholar